DavenportA.Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003.Perit Dial Int2009; 29: 297–302.
2.
BrownM.C., SimpsonK., KerssensJ.J., MactierR.A. on behalf of the Scottish Renal Registry. Peritoneal dialysis–associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000 – 2007).Perit Dial Int2011; 31: 639–50.
3.
KimD.K., YooT.H., RyuD.R., XuZ.G., KimH.J., ChoiK.H.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.Perit Dial Int2004; 24: 424–32.
4.
FunkeG., von GraevenitzA., ClarridgeJ.E.3rd, BernardK.A.Clinical microbiology of coryneform bacteria.Clin Microbiol Rev1997; 10: 125–59.
5.
GrunerE., PfyfferG.E., von GraevenitzA.Characterization of Brevibacterium spp. from clinical specimens.J Clin Microbiol1993; 31: 1408–12.
6.
PetitC.A., BosshardP.P., BrandtM.E., ClarridgeJ.E.3rd, FeldblyumT.V., FoxallP., Interpretive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing: approved Guideline.Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
WiklerM.A., FranklinR.C.3rd, BushK., DudleyM.N., EliopoulosG.M., HardyD.J., Performance Standards for antimicrobial Disk Susceptibility Tests: approved Standard.10th ed.Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
9.
JorgensenJ.H., HindlerJ.A., BernardK.A., CitronD.M., CockerillF.R., FritscheT.R., Methods for antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria: approved Guideline.2nd ed.Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
10.
FunkeG., CarlottiA.Differentiation of Brevibacterium spp. encountered in clinical specimens.J Clin Microbiol1994; 32: 1729–32.
11.
WautersG., HaaseG., AvesaniV., CharlierJ., JanssensM., Van BroeckJ.Identification of a novel Brevibacterium species isolated from humans and description of Brevibacterium sanguinis sp. nov.J Clin Microbiol2004; 42: 2829–32.
12.
AntoniouS., DimitriadisA., PolydorouF., MalakaE.Brevibacterium iodinum peritonitis associated with acute urticaria in a CAPD patient.Perit Dial Int1997; 17: 614–15.
13.
WautersG., Van BosterhautB., AvesaniV., CuvelierR., CharlierJ., JanssensM.Peritonitis due to Brevibacterium otitidis in a patient undergoing continuous ambulatory peritoneal dialysis.J Clin Microbiol2000; 38: 4292–3.
14.
FunkeG., PünterV., von GraevenitzA.Antimicrobial susceptibility patterns of some recently established coryneform bacteria.Antimicrob agents Chemother1996; 40: 2874–8.
15.
BrazzolaP., ZbindenR., RudinC., SchaadU.B., HeiningerU.Brevibacterium casei sepsis in an 18-year-old female with AIDS.J Clin Microbiol2000; 38: 3513–14.
UlrichS., ZbindenR., PaganoM., FischlerM., SpeichR.Central venous catheter infection with Brevibacterium sp. in an immunocompetent woman: case report and review of the literature.Infection2006; 34: 103–6. [Comment on Beukinga et al. (18)]
